logo

For the Inventor, By the Inventor

Søborg, Denmark

Zealand Pharma A/s


USPTO Granted Patents = 89



Trademarks = 19

Forward Citations = 1,043

Loading Chart...
Loading Chart...

108 inventors (with patents filed for the assignee):

goldMedal Bjarne Due Larsen (34 out of 39 patents)

silverMedal Ditte Riber (28 out of 31 patents)

bronzeMedal Jakob Lind Tolborg (17 out of 18 patents)

4.  Dieter Wolfgang Hamprecht (15 out of 35 patents)

5.  Rasmus Just (10 out of 10 patents)

6.  Eddi Meier (10 out of 12 patents)

7.  Lise Giehm (9 out of 9 patents)

8.  Torben Østerlund (8 out of 8 patents)

9.  Anne Pernille Tofteng Shelton (8 out of 8 patents)

10.  Pia Nørregaard (8 out of 8 patents)

11.  Keld Fosgerau (8 out of 8 patents)

12.  Yvette Miata Petersen (8 out of 8 patents)

13.  Manuel Perez Vazquez (7 out of 7 patents)

14.  Adam Paul Kafal (7 out of 7 patents)

15.  Jennifer L Hickey (7 out of 7 patents)


Core Competencies:
Peptide Delivery
Amylin Analogues
Cyclic Peptides
GLP-1 Agonists
GIP Agonists
Glucagon Analogues
KV1.3 Blockers
Integrin Inhibition
Hydraulic Drug Delivery
Medicament Delivery Devices
Diabetic Eye Disease Treatment
Fragment Synthesis

89 patents:

1. 12297251 - Injection pen for subcutaneous administration of a peptide (2025-05-13),
2. 12083164 - Amylin analogues (2024-09-10),
3. 12077611 - Cyclic peptides multimers targeting α4β7 integrin (2024-09-03),
4. 11957761 - Compounds having α4β7 integrin inhibition activity (2024-04-16),
5. 11884713 - Acylated glucagon analogues (2024-01-30),
6. 11814417 - GIP agonist compounds and methods (2023-11-14),
7. 11795204 - Glucagon analogues (2023-10-24),
8. 11780893 - Kv1.3 blockers (2023-10-10),
9. 11713338 - Cyclic peptides multimers targeting α-4-β-7 integrin (2023-08-01),
10. 11395847 - Acylated GLP-1/GLP-2 dual agonists (2022-07-26),
11. 11382956 - Amylin analogues (2022-07-12),
12. D955566 - Medicament delivery device (2022-06-21),
13. 11324799 - Gap junction intercellular communication modulators and their use for the treatment of diabetic eye disease (2022-05-10),
14. 11292820 - KV1.3 blockers (2022-04-05),
15. 11286281 - Homodetic cyclic peptides targeting alpha-4-beta-7 integrin (2022-03-29),
Zealand Pharma A/S is a biotechnology company focused on the discovery, development, and commercialization of peptide-based medicines. With a strong pipeline of innovative therapeutic candidates, Zealand Pharma aims to improve the lives of people with metabolic and gastrointestinal diseases, as well as other medical conditions. The company leverages its expertise in peptide drug discovery and development to create novel treatments that address unmet medical needs.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

...
89 Patents

#1 in Søborg

#44 in Denmark

#8,375 in the World

...
Søborg, Denmark

Zealand Pharma A/s

Forward Citations = 1,043

108 inventors:

goldMedal Bjarne Due Larsen (34 out of 39 patents)

silverMedal Ditte Riber (28 out of 31 patents)

bronzeMedal Jakob Lind Tolborg (17 out of 18 patents)

4.  Dieter Wolfgang Hamprecht (15 out of 35 patents)

5.  Rasmus Just (10 out of 10 patents)

Please report any incorrect information to support@idiyas.com
Loading…